RU2646457C2 - Терапевтическое средство при артрозе - Google Patents
Терапевтическое средство при артрозе Download PDFInfo
- Publication number
- RU2646457C2 RU2646457C2 RU2014123690A RU2014123690A RU2646457C2 RU 2646457 C2 RU2646457 C2 RU 2646457C2 RU 2014123690 A RU2014123690 A RU 2014123690A RU 2014123690 A RU2014123690 A RU 2014123690A RU 2646457 C2 RU2646457 C2 RU 2646457C2
- Authority
- RU
- Russia
- Prior art keywords
- group
- arthrosis
- hind limb
- formula
- phosphatidic acid
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/657163—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011247047 | 2011-11-11 | ||
| JP2011-247047 | 2011-11-11 | ||
| PCT/JP2012/076478 WO2013069404A1 (ja) | 2011-11-11 | 2012-10-12 | 関節症治療剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2014123690A RU2014123690A (ru) | 2015-12-20 |
| RU2646457C2 true RU2646457C2 (ru) | 2018-03-05 |
Family
ID=48289788
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2014123690A RU2646457C2 (ru) | 2011-11-11 | 2012-10-12 | Терапевтическое средство при артрозе |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9085593B2 (enExample) |
| EP (1) | EP2803359B1 (enExample) |
| JP (1) | JP5465815B2 (enExample) |
| KR (1) | KR101953181B1 (enExample) |
| CN (1) | CN103906519B (enExample) |
| AU (1) | AU2012337087B2 (enExample) |
| BR (1) | BR112014011315B8 (enExample) |
| CA (1) | CA2855660C (enExample) |
| ES (1) | ES2634008T3 (enExample) |
| IN (1) | IN2014CN04222A (enExample) |
| MY (1) | MY168931A (enExample) |
| PH (1) | PH12014501058B1 (enExample) |
| RU (1) | RU2646457C2 (enExample) |
| SG (1) | SG11201402226PA (enExample) |
| WO (1) | WO2013069404A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3483169B1 (en) | 2014-08-12 | 2021-05-26 | Otsuka Chemical Co., Ltd. | Crystal of cyclic phosphonic acid sodium salt and method for manufacturing same |
| JP6727596B1 (ja) | 2019-11-22 | 2020-07-22 | 国立大学法人お茶の水女子大学 | カルバリゾホスファチジン酸 |
| TWI868287B (zh) | 2019-12-23 | 2025-01-01 | 日商大塚化學股份有限公司 | carba-環狀磷脂酸化合物 |
| JP7736256B2 (ja) * | 2020-11-13 | 2025-09-09 | 株式会社マツモト交商 | 環状ホスファチジン酸含有組成物及び美容方法 |
| EP4252756A4 (en) * | 2020-11-26 | 2024-10-16 | Sansho Co., Ltd. | THERAPEUTIC AGENT FOR PULMONARY FIBROSIS |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002083149A1 (fr) * | 2001-04-13 | 2002-10-24 | Gencom Corporation | Medicaments contenant un acide phosphatique cyclique et favorisant la proliferation, la differentiation et/ou la survie de cellules gliales |
| WO2002083148A1 (fr) * | 2001-04-13 | 2002-10-24 | Gencom Corporation | Promoteurs de survie des cellules nerveuses a base de derive cyclique d'acide phosphatidique |
| WO2002094286A1 (fr) * | 2001-05-21 | 2002-11-28 | Gencom Corporation | Inhibiteurs de metastases cancereuses contenant des derives d'acide phosphatidique carbacycliques |
| WO2003104246A1 (ja) * | 2002-06-11 | 2003-12-18 | 株式会社ジェンコム | カルバ環状ホスファチジン酸誘導体 |
| WO2004091496A2 (en) * | 2003-04-11 | 2004-10-28 | The University Of Tennessee Research Foundation | Lysophosphatidic acid analogs and inhibition of neointima formation |
| RU2240131C1 (ru) * | 2003-04-04 | 2004-11-20 | Аладьев Сергей Иванович | Средство "артровит" для профилактики и лечения артритов и артрозов |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2700350B2 (ja) | 1990-04-20 | 1998-01-21 | 小糸工業株式会社 | 車両感知器 |
| JP3195833B2 (ja) | 1991-09-30 | 2001-08-06 | きみ子 室伏 | 新規生理活性物質及びその製造法 |
| JPH07149772A (ja) * | 1993-11-26 | 1995-06-13 | Sagami Chem Res Center | タンパク質リン酸化酵素cの活性促進剤 |
| JPH07258278A (ja) | 1994-03-18 | 1995-10-09 | Sagami Chem Res Center | 1−O−アシルグリセロール−2,3−ホスフェート誘導体を有効成分とするDNAポリメラーゼαの阻害剤 |
| JPH0925235A (ja) | 1995-07-13 | 1997-01-28 | Sagami Chem Res Center | 1−o−アシルグリセロール−2,3−ホスフェート誘導体を有効成分とするがん転移抑制剤 |
| JP2001178489A (ja) | 1999-12-24 | 2001-07-03 | Kimiko Murofushi | 環状ホスファチジン酸の製造法 |
| CN101163692B (zh) | 2005-02-16 | 2012-01-18 | 先灵公司 | 具有cxcr3拮抗活性的杂环取代的哌嗪 |
| KR20090097943A (ko) * | 2006-12-28 | 2009-09-16 | 오짜노미즈 유니버시티 | 환상 포스파티딘산 유도체를 포함하는 진통제 |
| JP2010189315A (ja) * | 2009-02-18 | 2010-09-02 | Unitika Ltd | 関節軟骨損傷治癒促進剤及びそれを含有する飲食品 |
-
2012
- 2012-10-12 CN CN201280055135.7A patent/CN103906519B/zh active Active
- 2012-10-12 KR KR1020147015608A patent/KR101953181B1/ko active Active
- 2012-10-12 US US14/357,089 patent/US9085593B2/en active Active
- 2012-10-12 MY MYPI2014701211A patent/MY168931A/en unknown
- 2012-10-12 PH PH1/2014/501058A patent/PH12014501058B1/en unknown
- 2012-10-12 EP EP12847890.6A patent/EP2803359B1/en active Active
- 2012-10-12 WO PCT/JP2012/076478 patent/WO2013069404A1/ja not_active Ceased
- 2012-10-12 IN IN4222CHN2014 patent/IN2014CN04222A/en unknown
- 2012-10-12 BR BR112014011315A patent/BR112014011315B8/pt active IP Right Grant
- 2012-10-12 CA CA2855660A patent/CA2855660C/en active Active
- 2012-10-12 RU RU2014123690A patent/RU2646457C2/ru active
- 2012-10-12 AU AU2012337087A patent/AU2012337087B2/en active Active
- 2012-10-12 JP JP2013542900A patent/JP5465815B2/ja active Active
- 2012-10-12 SG SG11201402226PA patent/SG11201402226PA/en unknown
- 2012-10-12 ES ES12847890.6T patent/ES2634008T3/es active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002083149A1 (fr) * | 2001-04-13 | 2002-10-24 | Gencom Corporation | Medicaments contenant un acide phosphatique cyclique et favorisant la proliferation, la differentiation et/ou la survie de cellules gliales |
| WO2002083148A1 (fr) * | 2001-04-13 | 2002-10-24 | Gencom Corporation | Promoteurs de survie des cellules nerveuses a base de derive cyclique d'acide phosphatidique |
| WO2002094286A1 (fr) * | 2001-05-21 | 2002-11-28 | Gencom Corporation | Inhibiteurs de metastases cancereuses contenant des derives d'acide phosphatidique carbacycliques |
| WO2003104246A1 (ja) * | 2002-06-11 | 2003-12-18 | 株式会社ジェンコム | カルバ環状ホスファチジン酸誘導体 |
| RU2240131C1 (ru) * | 2003-04-04 | 2004-11-20 | Аладьев Сергей Иванович | Средство "артровит" для профилактики и лечения артритов и артрозов |
| WO2004091496A2 (en) * | 2003-04-11 | 2004-10-28 | The University Of Tennessee Research Foundation | Lysophosphatidic acid analogs and inhibition of neointima formation |
Also Published As
| Publication number | Publication date |
|---|---|
| ES2634008T3 (es) | 2017-09-26 |
| IN2014CN04222A (enExample) | 2015-07-17 |
| JP5465815B2 (ja) | 2014-04-09 |
| EP2803359A1 (en) | 2014-11-19 |
| CN103906519B (zh) | 2017-10-10 |
| JPWO2013069404A1 (ja) | 2015-04-02 |
| HK1199406A1 (en) | 2015-07-03 |
| RU2014123690A (ru) | 2015-12-20 |
| EP2803359A4 (en) | 2015-12-16 |
| WO2013069404A1 (ja) | 2013-05-16 |
| PH12014501058B1 (en) | 2019-11-08 |
| BR112014011315B8 (pt) | 2020-09-15 |
| CA2855660A1 (en) | 2013-05-16 |
| NZ624870A (en) | 2016-01-29 |
| BR112014011315A2 (pt) | 2017-05-09 |
| EP2803359B1 (en) | 2017-04-19 |
| SG11201402226PA (en) | 2014-10-30 |
| MY168931A (en) | 2019-01-09 |
| US20140309194A1 (en) | 2014-10-16 |
| AU2012337087A1 (en) | 2014-06-05 |
| KR101953181B1 (ko) | 2019-02-28 |
| CN103906519A (zh) | 2014-07-02 |
| US9085593B2 (en) | 2015-07-21 |
| PH12014501058A1 (en) | 2014-06-23 |
| KR20140098778A (ko) | 2014-08-08 |
| AU2012337087B2 (en) | 2016-11-17 |
| BR112014011315B1 (pt) | 2020-03-03 |
| CA2855660C (en) | 2019-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CZ20004893A3 (en) | Compound similar to N-acyl dipeptide, process of its preparation and pharmaceutical preparation in which it is comprised | |
| US9085593B2 (en) | Therapeutic agent for arthrosis | |
| JP6568536B2 (ja) | パントテン酸キナーゼ関連神経変性症(pkan)の治療のための安定なパンテテイン誘導体およびそのような化合物の合成方法 | |
| EP1402894B1 (en) | Cancerous metastasis inhibitors containing carbacyclic phosphatidic acid derivatives | |
| EP2098237B1 (en) | Analgesic agent comprising cyclic phosphatidic acid derivative | |
| JP2002308779A (ja) | 環状ホスファチジン酸を含むグリア細胞の増殖、分化及び/又は生存の促進のための薬剤 | |
| JP6864899B2 (ja) | 損傷治療剤 | |
| JP4836345B2 (ja) | 環状ホスファチジン酸誘導体を含む神経細胞の生存促進剤 | |
| JP5747263B2 (ja) | 神経細胞死抑制剤 | |
| KR20060028630A (ko) | 이노시톨 폴리포스페이트 유도체 및 그의 사용 방법 | |
| HK1199406B (en) | Therapeutic agent for joint diseases | |
| JPH09227386A (ja) | ストレス蛋白質発現増強剤 | |
| NZ624870B2 (en) | Therapeutic agent for arthrosis | |
| WO2024210211A1 (ja) | アルツハイマー型認知症を中心とする認知症の改善・治療薬 | |
| TWI472326B (zh) | 去甲基斑蝥酸二鈉於調控人類樹突細胞之用途 | |
| KR20000048499A (ko) | 이노시톨 폴리포스페이트 유도체 및 그의 사용 방법 |